nach oben

Journal of Anesthesia

Erschienen in:

12.01.2021 | Review Article

Methadone: applications in pediatric anesthesiology and critical care medicine

verfasst von: Joseph D. Tobias

Erschienen in: Journal of Anesthesia | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Like morphine, methadone is a pure agonist at the µ opioid receptor. However, in distinction to morphine which has an elimination half-life of 2–3 h, methadone has an elimination half-life of 24–36 h. In addition to its effects at the µ opioid receptor, methadone is an antagonist at the n-methyl-d-aspartate (NMDA) receptor and also inhibits the reuptake of the neurotransmitters, serotonin and norepinephrine, in the central nervous system. Given its long half-life and high oral bioavailability, methadone has had a primary role in the outpatient treatment of patients with a history of opioid abuse or addiction. However, its unique pharmacology and cellular effects make it a valuable agent in the treatment of both acute and chronic pain of various etiologies. The following manuscript reviews the pharmacologic properties of methadone and discusses its clinical applications in the practice of pediatric anesthesiology and pediatric critical care medicine.

Gourlay GK, Wilson PR, Glynn CJ. Pharmacodynamics and pharmacokinetics of methadone during the perioperative period. Anesthesiology. 1982;57:458–67.PubMedCrossRef

Gourlay GK, Willis RJ, Wilson PR. Postoperative pain control with methadone: Influence of supplementary methadone doses and blood concentration–response relationships. Anesthesiology. 1984;61:19–26.PubMedCrossRef

Davis AM, Inturrisi CE. d-Methadone blocks morphine tolerance and N-methyl-d-aspartate–induced hyperalgesia. J Pharmacol Exp Ther. 1999;289:1048–53.PubMed

Sotgiu ML, Valente M, Storchi R, Caramenti G, Biella GE. Cooperative N-methyl-d-aspartate (NMDA) receptor antagonism and μ-opioid receptor agonism mediate the methadone inhibition of the spinal neuron pain-related hyperactivity in a rat model of neuropathic pain. Pharmacol Res. 2009;60:284–90.PubMedCrossRef

Codd EE, Shank RP, Schupsky JJ, Raffa RB. Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: Structural determinants and role in antinociception. J Pharmacol Exp Ther. 1995;274:1263–70.PubMed

Rojas-Corrales MO, Berrocoso E, Gibert-Rahola J, Micó JA. Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. Life Sci. 2002;72:143–52.PubMedCrossRef

Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. 2005;95:434–41.PubMedCrossRef

Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. New Engl J Med. 2003;348:1223–32.PubMedCrossRef

Anghelescu DL, Faughnan LG, Hankins GM, Ward DA, Oakes LL. Methadone use in children and young adults at a cancer center: a retrospective study. J Opioid Manag. 2011;7:353–61.PubMedPubMedCentralCrossRef

10.

Gourlay GK, Willis RJ, Lamberty J. A double-blind comparison of the efficacy of methadone and morphine in postoperative pain control. Anesthesiology. 1986;64:322–7.PubMedCrossRef

11.

Tobias JD, Schleien CL, Haun SE. Methadone as treatment for iatrogenic narcotic dependency in pediatric intensive care unit patients. Crit Care Med. 1990;18:1292–3.PubMedCrossRef

12.

Lugo RA, Satterfield KL, Kern SE. Pharmacokinetics of methadone. J Pain Pall Care Pharm. 2005;19:13–24.

13.

Price DD, Mayer DJ, Mao J, Caruso FS. NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance. J Pain Symptom Manage. 2000;19(1 Suppl):S7-11.PubMedCrossRef

14.

Davis AM, Inturrisi DE. d-Methadone blocks morphine tolerance and n-methyl-d-aspartate-induced hyperalgesia. J Pharm Exper Therap. 1999;289:1048–53.

15.

Garrido MJ, Trocóniz IF. Methadone: a review of its pharmacokinetic and pharmacodynamic properties. J Pharmacol Toxicol Methods. 1999;42:61–6.PubMedCrossRef

16.

Gerber JG, Rhodes RJ, Gal J. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19. Chirality. 2004;16:36–44.PubMedCrossRef

17.

Kharasch ED, Hoffer C, Whittington D, Sheffels P. Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition and miotic effects of methadone. Clin Pharmacol Ther. 2004;76:250–69.PubMedCrossRef

18.

Sharma A, Tallchief D, Blood J, Kim T, London A, Kharasch ED. Perioperative pharmacokinetics of methadone in adolescents. Anesthesiology. 2011;115:1153–61.PubMedPubMedCentralCrossRef

19.

Cobb MN, Desai J, Brown LS Jr, Zannikos PN, Rainey PM. The effect of fluconazole on the clinical pharmacokinetics of methadone. Clin Pharmacol Ther. 1998;63:655–62.PubMedCrossRef

20.

Lozano R, Domeque N, Frutos AJ. Methadone dosing in patients on ritonavir-boosted-based highly active antiretroviral therapy. Med Clin (Barc). 2019;15(152):161–2.CrossRef

21.

Shelton MJ, Cloen D, DiFrancesco R, Berenson CS, Esch A, de Caprariis PJ, Palic B, Schur JL, Buggé CJ, Ljungqvist A, Espinosa O, Hewitt RG. The effects of once-daily saquinavir/minidose ritonavir on the pharmacokinetics of methadone. J Clin Pharmacol. 2004;44:293–304.PubMedCrossRef

22.

Totah RA, Sheffels P, Roberts T, Whittington D, Thummel K, Kharasch ED. Role of CYP2B6 in stereoselective human methadone metabolism. Anesthesiology. 2008;108:363–74.PubMedCrossRef

23.

Kreek MJ, Schecter AJ, Gutjahr CL, Hecht M. Methadone use in patients with chronic renal disease. Drug Alcohol Dep. 1980;5:197–205.CrossRef

24.

Davison SN. Clinical pharmacology considerations in pain management in patients with advanced kidney failure. CJASN. 2019;14:917–31.PubMedCrossRef

25.

Furlan V, Hafi A, Dessalles MC, Bouchez J, Charpentier B, Taburet AM. Methadone is poorly removed by haemodialysis. Nephrol Dial Transplant. 1999;14:254–5.PubMedCrossRef

26.

Stemland CJ, Witte J, Colquhoun DA, Durieux ME, Langman LJ, Balireddy R, Thammishetti S, Abel MF, Anderson BJ. The pharmacokinetics of methadone in adolescents undergoing posterior spinal fusion. Paediatr Anaesth. 2013;23:51–7.PubMedCrossRef

27.

Ward RM, Drover DR, Hammer GB, Stemland CJ, Kern S, Tristani-Firouzi M, Lugo RA, Satterfield K, Anderson BJ. The pharmacokinetics of methadone and its metabolites in neonates, infants, and children. Paediatr Anaesth. 2014;24:591–601.PubMedPubMedCentralCrossRef

28.

Murphy GS, Szokol JW. Intraoperative methadone in surgical patients. Anesthesiology. 2019;131:678–92.PubMedCrossRef

29.

Shir Y, Shenkman Z, Shavelson V, Davidson EM, Rosen G. Oral methadone for the treatment of severe pain in hospitalized children: a report of five cases. Clin J Pain. 1998;14:350–3.PubMedCrossRef

30.

Berde CB, Beyer JE, Bournaki M-C, Levin CR, Sethna NF. Comparison of morphine and methadone for prevention of postoperative pain in 3- to 7-year-old children. J Pediatr. 1991;119:136–41.PubMedCrossRef

31.

Hamunen K. Ventilatory effects of morphine, pethidine and methadone in children. Br J Anaesth. 1993;70:414–8.PubMedCrossRef

32.

Singhal NR, Jones J, Semenova J, Williamson A, McCollum K, Tong D, Jerman J, Notrica DM, Nguyen H. Multimodal anesthesia with the addition of methadone is superior to epidural analgesia: a retrospective comparison of intraoperative anesthetic techniques and pain management for 124 pediatric patients undergoing the Nuss procedure. J Pediatr Surg. 2016;51:612–6.PubMedCrossRef

33.

Martin DP, Samora WP 3rd, Beebe AC, Klamar J, Gill L, Bhalla T, Veneziano G, Thung A, Tumin D, Barry N, Rice J, Tobias JD. Analgesic effects of methadone and magnesium following posterior spinal fusion for idiopathic scoliosis in adolescents: a randomized controlled trial. J Anesth. 2018;32:702–8.PubMedCrossRef

34.

Shir Y, Rosen G, Zeldin A, Davidson EM. Methadone is safe for treating hospitalized patients with severe pain. Can J Anaesth. 2001;48:1109–13.PubMedCrossRef

35.

Shir Y, Eimerl D, Magora F, Damm D, Schulte-Monting J, Chrubasik J. Plasma concentrations of methadone during postoperative patient-controlled extradural analgesia. Br J Anaesth. 1990;65:204–9.PubMedCrossRef

36.

Robinson JD, Caruso TJ, Wu M, Kleiman ZI, Kwiatkowski DM. Intraoperative methadone is associated with decreased perioperative opioid use without adverse events: a case-matched cohort study. J Cardiothorac Vasc Anesth. 2020;34:335–41.PubMedCrossRef

37.

Iguidbashian JP, Chang PH, Iguidbashian J, Lines J, Maxwell BG. Enhanced recovery and early extubation after pediatric cardiac surgery using single-dose intravenous methadone. Ann Card Anaesth. 2020;23:70–4.PubMedPubMedCentralCrossRef

38.

Barnett AM, Machovec KA, Ames WA, Homi HM, Turi JL, Koo J, Fuller M, Jooste EH.. The effect of intraoperative methadone during pediatric cardiac surgery on postoperative opioid requirements. Paediatr Anaesth (in press)

39.

Ripamonti C, Groff L, Brunelli C, Polastri D, Stavrakis A, De Conno F. Switching from morphine to oral methadone in treating cancer pain: What is the equianalgesic dose ratio? J Clin Oncol. 1998;16:3216–21.PubMedCrossRef

40.

Morley JS, Watt JW, Wells JC, Miles JB, Finnegan MJ, Leng G. Methadone in pain uncontrolled by morphine. Lancet. 1993;342:1243–6.PubMedCrossRef

41.

Manfredi PL, Borsook D, Chandler SW, Payne R. Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations. Pain. 1997;70:99–101.PubMedCrossRef

42.

Bruera E, Pereira J, Watanabe S, Belzile M, Kuehn N, Hanson J. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer. 1996;78:852–7.PubMedCrossRef

43.

Martinson IM, Nixon S, Geis D, YaDeau R, Nesbit M, Kersey J. Nursing care in childhood cancer. Methadone. Am J Nurs. 1982;432–435

44.

Miser AW, Miser JS. The use of oral methadone to control moderate and severe pain in children and young adults with malignancy. Clin J Pain. 1986;1:243–8.CrossRef

45.

Ettinger DS, Vitale PJ, Trump DL. Important clinical pharmacologic considerations in the use of methadone in cancer patients. Cancer Treat Rep. 1979;63:457–9.PubMed

46.

Kepes ER, Raj S, Thomas P, Vemulapalli K. Methadone and intravenous morphine requirements. Treatment of pain due to advanced cancer. N Y State J Med. 1983;83:925–7.PubMed

47.

Sabatowski R, Kasper SM, Radbruch L. Patient-controlled analgesia with intravenous L-methadone in a child with cancer pain refractory to high-dose morphine. J Pain Symptom Manage. 2002;23:3–5.PubMedCrossRef

48.

Davies D, DeVlaming D, Haines C. Methadone analgesia for children with advanced cancer. Pediatr Blood Cancer. 2008;51:393–7.PubMedCrossRef

49.

Arnold JH, Truog RD, Orav EJ, Scavone JM, Hershenson MB. Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation. Anesthesiology. 1990;73:1136–40.PubMedCrossRef

50.

Arnold JH, Truog RD, Scavone JM, Fenton T. Changes in the pharmacodynamic response to fentanyl in neonates during continuous infusion. J Pediatr. 1991;119:639–43.PubMedCrossRef

51.

Tobias JD, Deshpande JK, Gregory DF. Outpatient therapy of iatrogenic drug dependency following prolonged sedation in the pediatric intensive care unit. Intensive Care Med. 1994;20:504–7.PubMedCrossRef

52.

Tobias JD. Outpatient therapy of iatrogenic drug dependency following prolonged sedation in the pediatric intensive care unit. J Intensive Care Med. 1996;11:284–7.CrossRef

53.

Robertson RC, Darsey E, Fortenberry JD, Pettignano R, Hartley G. Evaluation of an opiate-weaning protocol using methadone in pediatric intensive care unit patients. Pediatr Crit Care Med. 2000;1:119–23.PubMedCrossRef

54.

Lugo RA, MacLaren R, Cash J, Pribble CG, Vernon DD. Enteral methadone to expedite fentanyl discontinuation and prevent opioid abstinence syndrome in the PICU. Pharmacotherapy. 2001;21:1566–73.PubMedCrossRef

55.

Meyer MT, Berens RJ. Efficacy of an enteral 10-day methadone wean to prevent opioid withdrawal in fentanyl-tolerant pediatric intensive care unit patients. Pediatr Crit Care Med. 2001;2:329–33.PubMedCrossRef

56.

Siddappa R, Fletcher JE, Heard AMB, Kielma D, Cimino M, Heard CM. Methadone dosage for prevention of opioid withdrawal in children. Pediatr Anesth. 2003;13:805–10.CrossRef

57.

Berens RJ, Meyer MT, Mikhailov TA, Colpaert KD, Czarnecki ML, Ghanayem NS, Hoffman GM, Soetenga DJ, Nelson TJ, Weisman SJ. A prospective evaluation of opioid weaning in opioid-dependent pediatric critical care patients. Anesth Analg. 2006;102:1045–50.PubMedCrossRef

58.

Ista E, van Dijk M, Gischler S, de Leeuw M, Poley MJ, Tibboel D. Weaning of opioids and benzodiazepines at home after critical illness in infants: a cost-effective approach. J Opioid Manag. 2010;6:55–62.PubMedCrossRef

59.

Vipond JM, Heiberger AL, Thompson PA, Huber JN. Shortened taper duration after implementation of a standardized protocol for iatrogenic benzodiazepine and opioid withdrawal in pediatric patients: results of a cohort study. Pediatr Qual Saf. 2018;18:e079.CrossRef

60.

Steineck KJ, Skoglund AK, Carlson MK, Gupta S. Evaluation of a pharmacist-managed methadone taper. Pediatr Crit Care Med. 2014;15:206–10.PubMedCrossRef

61.

Tobias JD. Methadone: who tapers, when, where, and how? Pediatr Crit Care Med. 2014;15:268–70.PubMedCrossRef

62.

Dervan LA, Yaghmai B, Watson RS, Wolf FM. The use of methadone to facilitate opioid weaning in pediatric critical care patients: a systematic review of the literature and meta-analysis. Paediatr Anaesth. 2017;27:228–39.PubMedCrossRef

63.

Bichaff P, Setani KT, Motta EHG, Delgado AF, Carvalho WB, Luglio M. Opioid tapering and weaning protocols in pediatric critical care units: a systematic review. Rev Assoc Med Bras. 2018;64:909–15.PubMedCrossRef

64.

Fenn NE 3rd, Plake KS. Opioid and benzodiazepine weaning in pediatric patients: review of current literature. Pharmacotherapy. 2017;37:1458–68.PubMedCrossRef

65.

Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Shear TD, Deshur MA, Vender JS, Benson J, Newmark RL. Clinical effectiveness and safety of intraoperative methadone in patients undergoing posterior spinal fusion surgery: a randomized, double-blinded, controlled trial. Anesthesiology. 2017;126:822–33.PubMedCrossRef

66.

Chui PT, Gin T. A double-blind randomised trial comparing postoperative analgesia after perioperative loading doses of methadone or morphine. Anaesth Intensive Care. 1992;20:46–51.PubMedCrossRef

67.

Udelsmann A, Maciel FG, Servian DC, Reis E, de Azevedo TM, Melo S. Methadone and morphine during anesthesia induction for cardiac surgery: Repercussion in postoperative analgesia and prevalence of nausea and vomiting. Rev Bras Anestesiol. 2011;61:695–701.PubMedCrossRef

68.

Bowdle TA, Even A, Shen DD, Swardstrom M. Methadone for the induction of anesthesia: plasma histamine concentration, arterial blood pressure, and heart rate. Anesth Analg. 2004;98:1692–7.PubMedCrossRef

69.

Wheeler AD, Tobias JD. Bradycardia during methadone therapy in an infant. Pediatr Crit Care Med. 2006;7:83–5.PubMedCrossRef

70.

Metcalfe J, Dunham MJ, Olsen GD, Krall MA. Respiratory and hemodynamic effects of methadone in pregnant women. Respir Physiol. 1980;42:383–93.PubMedCrossRef

71.

Seyler DE, Borowitz JL, Maickel RP. Calcium channel blockade by certain opioids. Fundam Appl Toxicol. 1983;3:536–42.PubMedCrossRef

72.

Atkinson D, Dunne A, Parker M. Torsades de pointes and self-terminating ventricular fibrillation in a prescription methadone user. Anaesthesia. 2007;62:952–5.PubMedCrossRef

73.

Andrews CM, Krantz MJ, Wedam EF, Marcuson MJ, Capacchione JF, Haigney MC. Methadone-induced mortality in the treatment of chronic pain: role of QT prolongation. Cardiol J. 2009;16:210–7.PubMed

74.

Chou R, Cruciani RA, Fiellin DA, Compton P, Farrar JT, Haigney MC, Inturrisi C, Knight JR, Otis-Green S, Marcus SM, Mehta D, Meyer MC, Portenoy R, Savage S, Strain E, Walsh S, Zeltzer L. American Pain Society; Heart Rhythm Society. Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. J Pain. 2014;15:321–37.PubMedCrossRef

75.

Stringer J, Welsh C, Tommasello A. Methadone-associated QT interval prolongation and torsades de pointes. Am J Health Syst Pharm. 2009;66:825–33.PubMedCrossRef

76.

van den Beuken-van Everdingen MH, Geurts JW, Patijn J. Prolonged QT interval by methadone: relevance for daily practice? A prospective study in patients with cancer and noncancer pain. J Opioid Manag. 2013;9:263–7.PubMedCrossRef

77.

Anghelescu DL, Patel RM, Mahoney DP, Trujillo L, Faughnan LG, Steen BD, Baker JN, Dl Pei. Methadone prolongs cardiac conduction in young patients with cancer-related pain. J Opioid Manag. 2016;12:131–8.PubMedPubMedCentralCrossRef

78.

Schwinghammer AJ, Wilson MD, Hall BA. Corrected QT interval prolongation in hospitalized pediatric patients receiving methadone. Pediatr Crit Care Med. 2018;19:e403–8.PubMedPubMedCentralCrossRef

79.

Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MC. QTc interval screening in methadone treatment. Ann Intern Med. 2009;150:387–95.PubMedCrossRef

80.

Baldo BA. Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects. Arch Toxicol. 2018;92:2457–73.PubMedCrossRef

81.

Mastroianni A, Ravaglia G. Serotonin syndrome due to co-administration of linezolid and methadone. Infez Med. 2017;25:263–6.PubMed

82.

Kumai M, Maeda Y, Miura M, Tsuruga K, Yamada T, Takekuma Y, Sugawara M. Serotonin syndrome developing immediately after the initiation of low-dose methadone therapy: a case report. Case Rep Oncol. 2020;13:281–4.

83.

Kharasch ED. Intraoperative methadone: rediscovery, reappraisal, and reinvigoration. Anesth Analg. 2011;112:13–6.PubMedPubMedCentralCrossRef

84.

Zanin A, Masiero S, Severino MS, Calderone M, Da Dalt L, Laverda AM. A delayed methadone encephalopathy: clinical and neuroradiological findings. J Child Neurol. 2010;25:748–51.PubMedCrossRef

Titel: Methadone: applications in pediatric anesthesiology and critical care medicine
verfasst von: Joseph D. Tobias
Publikationsdatum: 12.01.2021
Verlag: Springer Singapore
Erschienen in: Journal of Anesthesia / Ausgabe 1/2021
Print ISSN: 0913-8668
Elektronische ISSN: 1438-8359
DOI: https://doi.org/10.1007/s00540-020-02887-4

Neu im Fachgebiet AINS

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Methadone: applications in pediatric anesthesiology and critical care medicine

Abstract

Neu im Fachgebiet AINS

Mehr Frauen im OP – weniger postoperative Komplikationen

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Delir bei kritisch Kranken – Antipsychotika versus Placebo

Klinikreform soll zehntausende Menschenleben retten

Update AINS

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Predicting cardiac risk in noncardiac surgery: a narrative review

A modified algorithm for choosing the most appropriate intraoperative pacemaker mode for patients with permanent pacemaker in non-cardiac surgery

Effects of anesthetic agents on contractions of the pregnant rat myometrium in vivo and in vitro

Validation of the Japanese version of the Bath CRPS Body Perception Disturbance Scale for CRPS

Steroid-induced rapid recovery from respiratory dysfunction in a patient with myasthenia gravis after spinal anesthesia

Update to the handling of “Preprints” by the Journal of Anesthesia

Neu im Fachgebiet AINS

Mehr Frauen im OP – weniger postoperative Komplikationen

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Delir bei kritisch Kranken – Antipsychotika versus Placebo

Klinikreform soll zehntausende Menschenleben retten

Update AINS